[en] BACKGROUND: Myeloperoxidase (MPO) is a member of the peroxidase-cyclooxygenase superfamily, which is secreted from stimulated leucocytes at inflammatory sites. It is well known that MPO catalyses oxidation reactions via the release of reactive halogenating and nitrating species and thus induces tissue damage. Several studies have already implicated MPO in the development of neoplasia. Chronic or recurrent prostatic inflammation has long been recognized as having the potential to initiate and promote the development of prostate cancer. The objective was to investigate whether MPO is present in the prostate. METHODS: Human prostate material was obtained from biopsies, transurethral resections of the prostate (TURP), prostatic adenomectomies, and retropubic radical prostatectomies. Twenty-nine slides of normal prostate tissue, benign prostatic hyperplasia (BPH), and prostate cancer were reviewed by a pathologist. Immunohistochemical analysis using MPO-specific human antibody was performed to detect MPO in the prostate tissue. RESULTS: Immunocytohistochemistry showed cellular colocalization of MPO in the secretory epithelial cells of the prostate with staining varying from light to strong intensity. Staining in the glandular apical snouts was often reinforced although staining of basal as well as of luminal glandular cells was also present. CONCLUSIONS: We identified, for the first time, the presence of MPO at the surface of prostatic epithelial cells. In view of the pro-oxidant properties of this enzyme, further research is needed to define whether MPO contributes to the development of prostatic lesions. Prostate 72:507-513, 2012. (c) 2011 Wiley Periodicals, Inc.
Research center :
CORD - Centre de l'Oxygène, Recherche et Développement - ULiège
Roumeguere, Thierry; Université Libre de Bruxelles - ULB > CHU Charleroi > Laboratory of Experimental Medicine
Delree, Paul; Institute of Pathologyand Genetics (IPG),Gosselies, Belgium
Van Antwerpen, Pierre; Université Libre de Bruxelles - ULB > Faculty of Pharmacy > Laboratory of Pharmaceutical Chemistry and Analytical Platform
Rorive, S.
Vanhamme, L.
de Ryhove, L de la Kethulle
Serteyn, Didier ; Université de Liège - ULiège > Département clinique des animaux de compagnie et des équidés > Anesthésiologie gén. et pathologie chirurg. des grds animaux
Wespes, E.
Vanhaerverbeek, M.
Boudjeltia, K Zouaoui; Université Libre de Bruxelles - ULB > CHU Charleroi > Laboratory of Experimental Medicine
Language :
English
Title :
Intriguing location of myeloperoxidase in the prostate: A preliminary immunohistochemical study.
Alcaraz, A., Hammerer, P., Tubaro, A., Schröder, F., Castro, R., Is there evidence of a relationship between benign prostatic hyperplasia and prostate cancer? Findings of a literature review (2009) Eur Urol, 55, pp. 864-875
Schottenfeld, D., Beebe-Dimmer, J., Chronic inflammation: A common and important factor in the pathogenesis of neoplasia (2006) CA Cancer J Clin, 56 (2), pp. 69-83
De Marzo, A.M., Marchi, V.L., Epstein, J.I., Nelson, W.G., Proliferative inflammatory atrophy of the prostate (1999) Am J Pathol, 155, pp. 1985-1992
Ludwig, M., Vidal, A., Diemer, T., Pabst, W., Failing, K., Weidner, W., Chronic prostatitis/chronic pelvic pain syndrome: Seminal markers of inflammation (2003) World J Urol, 21, pp. 82-85
Klebanoff, S.J., Myeloperoxidase: Friend and foe (2005) J Leukoc Biol, 77, pp. 598-625
Boudjeltia, K.Z., Legssyer, I., Van Antwerpen, P., Kisoka, R.L., Babar, S., Moguilevsky, N., Delree, P., Brohee, D., Triggering of inflammatory response by myeloperoxidase-oxidized LDL (2006) Biochem Cell Biol, 84 (5), pp. 805-812
Kramer, G., Mitteregger, D., Marberger, M., Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? (2007) Eur Urol, 51, pp. 1202-1216
Nickel, J.C., Roehrborn, C.G., O'Leary, M.P., Bostwick, D.G., Somerville, M.C., Rittmaster, R.S., The relationship between prostate inflammation and lower urinary tract symptoms: Examination of baseline data from the REDUCE trial (2008) Eur Urol, 54, pp. 1379-1384
Sciarra, A., Di Silverio, F., Salciccia, S., Autran Gomez, A.M., Gentilucci, A., Gentile v inflammation and chronic prostatic diseases: Evidence for a link? (2007) Eur Urol, 52, pp. 964-972
MacLennan, G.T., Eisenberg, R., Fleshman, R.L., Taylor, J.M., Fu, P., Resnick, M.I., Gupta, S., The influence of chronic inflammation in prostatic carcinogenesis: A 5-year follow-up study (2006) J Urol, 176, pp. 1012-1016
Prakash, K., Pirozzi, G., Elashoff, M., Munger, W., Waga, I., Dhir, R., Kakehi, Y., Getzenberg, R.H., Symptomatic and asymptomatic benign prostatic hyperplasia: Molecular differentiation by using microarrays (2002) Proc Natl Acad Sci USA, 99, pp. 7598-7603
Güngor, N., Godschalk, R., Pachen, D., Van Schooten, F.J., Knaapen, A.M., Activated neutrophils inhibit nucleotide excision repair in human pulmonary epithelial cells: Role of myeloperoxidase (2007) FASEB J, 21, pp. 2236-2359
Schabath, M.B., Spitz, M.R., Zhang, X., Delclos, G.L., Wu, X., Genetic variants of myeloperoxidase and lung cancer risk (2000) Carcinogenesis, 21, pp. 1163-1166
Ambrosone, C., Ahn, J., Singh, K., Rezaishiraz, H., Furberg, H., Sweeney, C., Coles, B., Trovato, A., Polymorphisms in genes related to oxidative stress (MPO, MnSOD, CAT) and survival after treatment for breast cancer (2005) Cancer Res, 65 (3), pp. 1105-1111
Hung, R.J., Boffetta, P., Brennan, P., Malaveille, C., Gelatti, U., Placidi, D., Carta, A., Porru, S., Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk (2004) Carcinogenesis, 25 (6), pp. 973-978
Palapattu, G.S., Sutcliffe, S., Bastain, P.J., Platz, E.A., Prostate carcinogenesis and inflammation: Emerging insights (2004) Carcinogenesis, 26, pp. 1170-1181
Sugar, L.M., Inflammation and prostate cancer (2006) Can J Urol, 13 (SUPPL. 1), pp. 46-47
Van Antwerpen, P., Slomianny, M.C., Boudjeltia, K.Z., Delporte, C., Faid, V., Calay, D., Rousseau, A., Michalski, J.C., Glycosylation pattern of mature dimeric leukocyte and recombinant monomeric myeloperoxidase: Glycosylation is required for optimal enzymatic activity (2010) J Biol Chem, 285, pp. 16351-16359
Henderson, J.P., Byun, J., Heinecke, J.W., Molecular chlorine generated by the myeloperoxidase-hydrogen peroxide-chloride system of phagocytes produces 5-chlorocytosine in bacterial RNA (1999) J Biol Chem, 274 (47), pp. 33440-33448
Jiang, Q., Blount, B.C., Ames, B.N., 5-Chlorouracil, a marker of DNA damage from hypochlorous acid during inflammation (2003) J Biol Chem, 278 (35), pp. 32834-32840
Iwamoto, H., Kobayashi, T., Hasegawa, E., Morita, Y., Reaction of human myeloperoxidase with hydrogen peroxide and its true catalase activity (1987) J Biochem, 101 (6), pp. 1407-1412
Kettle, A.J., Winterbourn, C.C., A kinetic analysis of the catalase activity of myeloperoxidase (2001) Biochemistry, 40 (34), pp. 10204-10212
